Acusphere, Inc.
Acusphere, Inc. (ACUS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
acus · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Acusphere, Inc.You ACUS | $0M | N/A | — | -$12.60 |
 Aequus Pharmaceuticals Inc. AQSZF | $0M | N/A | — | -$0.02 |
 Black Bird Biotech, Inc. BBBT | $0M | N/A | — | -$0.01 |
 Golden Developing Solutions, Inc. DVLP | $0M | N/A | — | -$0.00 |
 IR Biosciences Holdings Inc. IRBS | $0M | N/A | — | -$0.31 |
 MultiCorp International, Inc. MCIC | $0M | N/A | — | -$0.00 |
 Neptune Wellness Solutions Inc. NEPTF | $0M | N/A | — | -$8190.15 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Acusphere, Inc. (ACUS) measures how much investors pay for each dollar of the company's trailing earnings. ACUS's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$12.60.
Frequently asked questions
ACUS pe ratio · 6 questionsACUS's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$12.60. Data sourced from Financial Modeling Prep via ACUS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Acusphere, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09